Communiqués Manhattan Scientifics, Inc.

Actions

MHTX

US5631221000

Temps Différé OTC Markets Autres places de cotation 20:00:38 05/06/2024			Varia. 5j.	Varia. 1 janv.
0,0015 ^USD	-21,05%		-21,05%	-42,31%

15/05	Manhattan Scientifics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
10/04	Manhattan Scientifics, Inc annonce la démission de Frank Georgiou en tant que membre du conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Imagion Expands Collaboration with Siemens Healthineers to United States	29/06/23	BU
Manhattan Scientifics Celebrates Imagion Biosystems' Milestones in Early Cancer Detection Technology	31/05/23	BU
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	13/04/23	AQ
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/11/22	AQ
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/08/22	AQ
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/05/22	AQ
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	06/04/22	AQ
Manhattan Scientifics Announces Early Results from Cancer Company	17/03/22	BU
MANHATTAN SCIENTIFICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/11/21	AQ
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23/08/21	AQ
Imagion Biosystems First-in-Human Study Update: First Patient Enrolled	26/05/21	PU
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	17/05/21	AQ
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	15/04/21	AQ
Manhattan Scientifics : Imagion Biosystems 2020 Full-Year Results	25/02/21	PU
Manhattan Scientifics : MHTX Former Wholly Owned Sub Announces Breast Cancer Diagnostic Test Begin with First-in-Human Study	17/12/20	PU
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/11/20	AQ
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	19/08/20	AQ
Manhattan Scientifics : Metals Licensee Featured in Titanium Today Issue	18/08/20	PU
MANHATTAN SCIENTIFICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	20/05/20	AQ
MANHATTAN SCIENTIFICS INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	12/05/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Manhattan Scientifics, Inc.

Actions

MHTX

US5631221000

Communiqués

Filtres